Neticonazole
Neticonazole is an imidazole derivative and a potent and long-acting antifungal agent. Neticonazole has anti-infection and anti-cancer effects[1][2][3].
Product Specifications
CAS Number
130726-68-0
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Fungal
Type
Reference compound
Related Pathways
Anti-infection
Applications
Cancer-programmed cell death
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/neticonazole.html
Purity
99.88
Solubility
1M HCl : 100 mg/mL (ultrasonic; adjust pH to 1 with HCl) |DMSO : 250 mg/mL (ultrasonic) |H2O : < 0.1 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CCCCCOC1=CC=CC=C1/C(N2C=CN=C2)=C\SC
Molecular Formula
C17H22N2OS
Molecular Weight
302.43
Precautions
H302, H315, H319
References & Citations
[1]Tsuboi R, et al. Hyperkeratotic chronic tinea pedis treated with neticonazole cream. Neticonazole Study Group. Int J Dermatol. 1996 May;35 (5) :371-3.|[2]Datta A, et al. High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: A drug repurposing strategy for advanced cancer. Sci Rep. 2018 May 25;8 (1) :8161.|[3]Gu L, et al. The exosome secretion inhibitor neticonazole suppresses intestinal dysbacteriosis-induced tumorigenesis of colorectal cancer. Invest New Drugs. 2020 Apr;38 (2) :221-228.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6277781-01 0.2 mL
BCAS1, NT (BCAS1, AIBC1, NABC1, Breast carcinoma-amplified sequence 1, Amplified and overexpressed in breast cancer, Novel amplified in breast cancer 1) (Biotin)
Sign In for Pricing
View Details MBS6277781-02 5x 0.2 mL
BCAS1, NT (BCAS1, AIBC1, NABC1, Breast carcinoma-amplified sequence 1, Amplified and overexpressed in breast cancer, Novel amplified in breast cancer 1) (Biotin)
Sign In for Pricing
View Details 
